Bouché Clara, Serdy Shanti, Kahn C Ronald, Goldfine Allison B
Harvard Medical School, Boston, Massachusetts 02115, USA.
Endocr Rev. 2004 Oct;25(5):807-30. doi: 10.1210/er.2003-0026.
Type 2 diabetes is a complex disorder with diminished insulin secretion and insulin action contributing to the hyperglycemia and wide range of metabolic defects that underlie the disease. The contribution of glucose metabolic pathways per se in the pathogenesis of the disease remains unclear. The cellular fate of glucose begins with glucose transport and phosphorylation. Subsequent pathways of glucose utilization include aerobic and anaerobic glycolysis, glycogen formation, and conversion to other intermediates in the hexose phosphate or hexosamine biosynthesis pathways. Abnormalities in each pathway may occur in diabetic subjects; however, it is unclear whether perturbations in these may lead to diabetes or are a consequence of the multiple metabolic abnormalities found in the disease. This review is focused on the cellular fate of glucose and relevance to human type 2 diabetes.
2型糖尿病是一种复杂的疾病,胰岛素分泌减少和胰岛素作用减弱导致血糖升高以及构成该疾病基础的广泛代谢缺陷。葡萄糖代谢途径本身在该疾病发病机制中的作用仍不清楚。葡萄糖的细胞命运始于葡萄糖转运和磷酸化。随后的葡萄糖利用途径包括有氧和无氧糖酵解、糖原形成以及在磷酸己糖或己糖胺生物合成途径中转化为其他中间体。糖尿病患者可能在每个途径中都出现异常;然而,尚不清楚这些途径的紊乱是导致糖尿病的原因还是该疾病中发现的多种代谢异常的结果。本综述聚焦于葡萄糖的细胞命运及其与人类2型糖尿病的相关性。